SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-18-001855
Filing Date
2018-03-12
Accepted
2018-03-12 14:51:31
Documents
77
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f10k_022718p.htm 10-K 1142613
2 EXHIBIT 10.88 exh_1088.htm EX-10.88 256938
3 EXHIBIT 21 exh_21.htm EX-21 2476
4 EXHIBIT 23 exh_23.htm EX-23 10788
5 EXHIBIT 31.1 exh_311.htm EX-31.1 7036
6 EXHIBIT 31.2 exh_312.htm EX-31.2 7050
7 EXHIBIT 32.1 exh_321.htm EX-32.1 4010
8 EXHIBIT 32.2 exh_322.htm EX-32.2 4139
15 GRAPHIC graph_1.jpg GRAPHIC 38558
16 GRAPHIC exh1088_01.jpg GRAPHIC 297929
  Complete submission text file 0001171843-18-001855.txt   7113743

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE bcrx-20171231.xml EX-101.INS 1175482
10 XBRL SCHEMA FILE bcrx-20171231.xsd EX-101.SCH 74613
11 XBRL CALCULATION FILE bcrx-20171231_cal.xml EX-101.CAL 57454
12 XBRL DEFINITION FILE bcrx-20171231_def.xml EX-101.DEF 534025
13 XBRL LABEL FILE bcrx-20171231_lab.xml EX-101.LAB 472760
14 XBRL PRESENTATION FILE bcrx-20171231_pre.xml EX-101.PRE 551624
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 18683093
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1